收费全文 | 79239篇 |
免费 | 7537篇 |
国内免费 | 5260篇 |
耳鼻咽喉 | 837篇 |
儿科学 | 870篇 |
妇产科学 | 1221篇 |
基础医学 | 10428篇 |
口腔科学 | 1399篇 |
临床医学 | 10359篇 |
内科学 | 11555篇 |
皮肤病学 | 1018篇 |
神经病学 | 4379篇 |
特种医学 | 3055篇 |
外国民族医学 | 53篇 |
外科学 | 8321篇 |
综合类 | 10663篇 |
现状与发展 | 21篇 |
一般理论 | 22篇 |
预防医学 | 4886篇 |
眼科学 | 2954篇 |
药学 | 8312篇 |
65篇 | |
中国医学 | 4147篇 |
肿瘤学 | 7471篇 |
2024年 | 90篇 |
2023年 | 1091篇 |
2022年 | 1622篇 |
2021年 | 3499篇 |
2020年 | 2979篇 |
2019年 | 2883篇 |
2018年 | 3065篇 |
2017年 | 2540篇 |
2016年 | 2639篇 |
2015年 | 3795篇 |
2014年 | 4715篇 |
2013年 | 4159篇 |
2012年 | 6177篇 |
2011年 | 6615篇 |
2010年 | 4075篇 |
2009年 | 3085篇 |
2008年 | 4286篇 |
2007年 | 4140篇 |
2006年 | 4248篇 |
2005年 | 4081篇 |
2004年 | 2774篇 |
2003年 | 2537篇 |
2002年 | 2072篇 |
2001年 | 1779篇 |
2000年 | 1770篇 |
1999年 | 2040篇 |
1998年 | 1263篇 |
1997年 | 1241篇 |
1996年 | 941篇 |
1995年 | 903篇 |
1994年 | 765篇 |
1993年 | 481篇 |
1992年 | 594篇 |
1991年 | 497篇 |
1990年 | 471篇 |
1989年 | 411篇 |
1988年 | 371篇 |
1987年 | 291篇 |
1986年 | 248篇 |
1985年 | 210篇 |
1984年 | 129篇 |
1983年 | 86篇 |
1982年 | 42篇 |
1981年 | 51篇 |
1980年 | 29篇 |
1979年 | 63篇 |
1978年 | 22篇 |
1974年 | 27篇 |
1973年 | 18篇 |
1968年 | 16篇 |
Background
Given the lack of established indications for elective nodal irradiation (ENI) in ypN0 patients after neoadjuvant chemotherapy (NAC) and breast-conserving surgery (BCS), we set out to investigate the role of ENI in ypN0 patients according to subtype and pathologic complete remission (pCR) status.Patients and Methods
We analyzed 261 patients who received NAC followed by BCS and adjuvant radiotherapy in 13 institutions of the Korean Radiation Oncology Group from 2005 to 2011. The tumors were classified into one of 3 subtypes: luminal (estrogen receptor positive or progesterone receptor positive and HER2 negative), HER2 (HER2 positive), or triple negative (estrogen receptor, progesterone receptor, and HER2 negative). We compared locoregional control (LRC), disease-free survival (DFS), and overall survival (OS) according to ENI in different subgroups generated by the subtype and pCR statuses.Results
In all patients, the 5-year LRC, DFS, and OS rates were 96.0%, 91.0%, and 96.8%, respectively. In all patients, axillary lymph node dissection was found to be the only favorable factor for LRC (P = .023) and DFS (P = .001). Age ≥ 50 years (P = .027), negative resection margin (P = .002), and axillary lymph node dissection (P = .002) were all favorable factors for OS. ENI did not affect LRC, DFS, or OS. Subgroup analysis by tumor subtype and pCR showed that ENI was not associated with greater LRC or DFS in any subgroups.Conclusion
In ypN0 patients after NAC and BCS, ENI did not improve LRC or survival, regardless of subtype or primary tumor response. This result should be verified through larger prospective trials. 相似文献Methods: Fifty-four patients with ACI and 51 healthy controls were included in our study. Baseline characteristics and blood samples were collected for further analysis. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure the serum miR-124 levels. The dual-luciferase reporter assay was used to evaluate the effect of miR-124 on iASPP, a protein that inhibits apoptosis stimulating proteins in the p53 family.
Results: Compared with normal controls, the miR-124 levels in the ACI group rapidly decreased at phase 1 (within 24?h after ischemia) (p?<?0.001) and then gradually increased at phase 2 (48?~?72?h after ischemia) (p?<?0.001) and phase 3 (the 7th day after ischemia) (p?<?0.001). The dual-luciferase reporter assay showed that miR-124 down-regulates iASPP expression in 293T cells.
Conclusion: The miR-124 levels are down-regulated in ACI patients. The dynamic changes of miR-124 might provide a possible method for the detection of ischemic stroke.
- Highlights
The difference in miR-124 expression levels between ACI patients and normal controls.
Dynamic changes of miR-124 expression levels in ACI patients.
The down-regulation of miR-124 upon iASPP expression.